HPV infection is the most common sexually transmitted infection in Europe and the United States. HPV vaccination in regard to cervical cancer development has been researched significantly in the last years. The vaccines have been deemed efficacious, safe and cost-effective. Research now seems to be shifting with more articles being published on disease burden and vaccination efficacy in males as well as the on other HPV-related diseases.